Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A papillary carcinoma of the thyroid gland measuring 10mm or less in diameter. The survival rates of patients with this type of carcinoma are the same with those of the normal population.
Biomarker and diagnostic research for papillary thyroid Microcarcinoma has been reported in the published literature.
10 clinical trials registered, 5 recruiting. Interventions under study include other interventions, procedural interventions, drug therapy, and gene therapy. Pipeline includes 1 PHASE2, 2 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT02609685](https://clinicaltrials.gov/study/NCT02609685) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:59 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Active Surveillance of Papillary Thyroid Microcarcinoma |
NA |
Cedars-Sinai Medical Center |
RECRUITING |
[NCT07054229](https://clinicaltrials.gov/study/NCT07054229) | Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study | — | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | RECRUITING |
[NCT06333587](https://clinicaltrials.gov/study/NCT06333587) | Minimally Invasive Treatments of the Thyroid | — | European Institute of Oncology | RECRUITING |
[NCT02363595](https://clinicaltrials.gov/study/NCT02363595) | Genomic Predictors of Papillary Microcarcinoma Disease Progression | — | Memorial Sloan Kettering Cancer Center | RECRUITING |
[NCT05189821](https://clinicaltrials.gov/study/NCT05189821) | RFA Treatment for Papillary Thyroid Microcarcinoma | — | Columbia University | RECRUITING |
202 publications have been identified in PubMed for papillary thyroid Microcarcinoma. Kisho has analyzed 143 by research type. Research spans Epidemiology / Natural History (25%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (20%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 36 | 25% |
Testing and diagnosis research | 29 | 20% |
Research summaries | 28 | 20% |
Clinical study results | 22 | 15% |
Laboratory research | 15 | 10% |
Patient case studies | 8 | 6% |
Other research | 3 | 2% |
New treatment approaches | 2 | 1% |
Capito JE (2026). [PMID: 41939180](https://pubmed.ncbi.nlm.nih.gov/41939180/). *Case Rep Womens Health*. [Case Report / Case Series]
Kuo JH (2026). [PMID: 41706465](https://pubmed.ncbi.nlm.nih.gov/41706465/). *JAMA Surg*. [Basic Science / Preclinical]
Zhu X (2026). [PMID: 41715255](https://pubmed.ncbi.nlm.nih.gov/41715255/). *Eur J Med Res*. [Basic Science / Preclinical]
Zhang W (2026). [PMID: 41478265](https://pubmed.ncbi.nlm.nih.gov/41478265/). *Oral Oncol*. [Clinical Trial Publication]
Pang N (2026). [PMID: 42222094](https://pubmed.ncbi.nlm.nih.gov/42222094/). *Front Endocrinol (Lausanne)*. [Clinical Trial Publication]
van Dijk SPJ (2026). [PMID: 41452620](https://pubmed.ncbi.nlm.nih.gov/41452620/). *JAMA Otolaryngol Head Neck Surg*. [Review / Meta-Analysis]
Dong S (2026). [PMID: 41629869](https://pubmed.ncbi.nlm.nih.gov/41629869/). *BMC Surg*. [Clinical Trial Publication]
Farnin R (2026). [PMID: 42153056](https://pubmed.ncbi.nlm.nih.gov/42153056/). *Cureus*. [Case Report / Case Series]
Zhu F (2026). [PMID: 41936010](https://pubmed.ncbi.nlm.nih.gov/41936010/). *Discov Oncol*. [Diagnostic / Biomarker]
Jiang L (2026). [PMID: 41543346](https://pubmed.ncbi.nlm.nih.gov/41543346/). *Clin Cancer Res*. [Diagnostic / Biomarker]
AI-curated news mentioning papillary thyroid Microcarcinoma
Updated Jul 21, 2026
A case report highlights the synchronous occurrence of oral squamous cell carcinoma and aggressive papillary thyroid microcarcinoma, along with regional metastasis in cervical lymph nodes. This finding may provide insights into the complex interactions between these cancers.